Internal Medicine, Rheumatology · Brooklyn, NY
NPI
1508941899
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4802 10th Ave
Brooklyn, NY, 11219
Phone (718) 283-8773
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
992 services
Medicare patients, 2024
453
Average age 74
Drug cost, 2024
$9.0M
5,588 prescriptions
Company payments, 2025
$2,780
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yevgeniya Margulis was code 99214 (office e&m - established), 503 times for 261 patients. In total Yevgeniya Margulis billed 992 services in 12 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 503 | 261 | $77.84 | $39K |
| 99213 Office E&M - Established | Facility | 312 | 216 | $53.32 | $17K |
| 99203 Office E&M - New | Facility | 96 | 96 | $71.29 | $6,843 |
| 99204 Office E&M - New | Facility | 68 | 68 | $103.95 | $7,069 |
By year: 2022 $68K for 1,024 services; 2023 $74K for 1,107 services; 2024 $70K for 992 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yevgeniya Margulis prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 746 prescriptions and refills. In total Yevgeniya Margulis wrote 5,588 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 746 | 1,073 | 139 | $15K |
| Celecoxib Generic | 543 | 601 | 190 | $15K |
| Prednisone Generic | 500 | 597 | 126 | $2,787 |
| Humira(Cf) Pen Adalimumab | 325 | 343 | 42 | $2.4M |
| Methylprednisolone Generic | 317 | 349 | 76 | $4,583 |
| Hydroxychloroquine Sulfate Generic | 292 | 418 | 57 | $6,728 |
| Enbrel Sureclick Etanercept | 279 | 314 | 39 | $2.3M |
| Alendronate Sodium Generic | 201 | 308 | 52 | $973 |
| Folic Acid Generic | 182 | 288 | 35 | $384 |
| Diclofenac Sodium Generic | 155 | 166 | 43 | $60K |
| Allopurinol Generic | 139 | 211 | 36 | $792 |
| Rasuvo Methotrexate/Pf | 131 | 133 | 18 | $69K |
| Colchicine Generic | 92 | 128 | 28 | $3,443 |
| Leflunomide Generic | 81 | 137 | 18 | $3,425 |
| Xeljanz Xr Tofacitinib Citrate | 78 | 88 | 11 | $486K |
Brand drugs: 1,680 claims; generic drugs: 3,853 claims; opioid claims: 79.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yevgeniya Margulis $2,780 ($2,780 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $1,116.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 38 | $1,116 |
| Janssen Biotech, Inc. JNJ | 38 | $577 |
| Amgen Inc. AMGN | 23 | $388 |
| Pfizer Inc. PFE | 12 | $217 |
| UCB, Inc. UCB.BR | 10 | $196 |
| Novartis Pharmaceuticals Corporation NVS | 18 | $153 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $47.47 |
| Fresenius Kabi USA, LLC | 2 | $45.77 |
| Aurinia Pharma U.S., Inc. AUPH | 1 | $25.16 |
| Radius Health, Inc. | 1 | $15.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.